Skip to main content
Top
Published in: Head and Neck Pathology 1/2021

01-03-2021 | Case Reports

Segmental Ipsilateral Odontognathic Dysplasia (Mandibular Involvement in Segmental Odontomaxillary Dysplasia?) and Identification of PIK3CA Somatic Variant in Lesional Mandibular Gingival Tissue

Authors: Tanya M. Gibson, Keith Rafferty, Elyse Ryan, Arupa Ganguly, Ioannis G. Koutlas

Published in: Head and Neck Pathology | Issue 1/2021

Login to get access

Abstract

Segmental odontomaxillary dysplasia (SOD) is a developmental condition of the middle and posterior maxilla featuring dysplastic bone overgrowth, dental abnormalities and, occasionally, various homolateral cutaneous manifestations. Herein, we describe an individual with maxillary abnormality akin to SOD and associated ipsilateral segmental odontomandibular dysplasia. Also, the result of the evaluation of lesional mandibular gingival tissue for overgrowth-related gene variants is reported. An 8-year-old girl presented clinically with congenital maxillary and mandibular alveolar soft tissue enlargement in the area of the premolars. A panoramic radiograph revealed abnormal trabeculation essentially similar to SOD in the maxilla and mandible with congenitally missing maxillary and mandibular first and second premolars and mandibular canines. Diagnostic mandibular bone biopsy was performed and lesional mandibular gingival hyperplastic tissue was obtained for variant analysis of somatic overgrowth genes PIK3CA, AKT1, AKT3, GNAQ, GNA11, MTOR, PIK3R2. Cone beam computerized tomography (CBCT) disclosed osseous abnormalities on the left side of the maxilla and mandible and very mild osseous expansion in the mandible. Histologically, abnormal bone exhibiting prominent reversal lines was present and associated with fibrocollagenous tissue. Genomic DNA analysis disclosed PIK3CAc.1571G>A; pArg524Lys which was seen at a low mosaic level in the blood, indicating a post-zygotic change. Although this case may be a unique disorder, by sharing features with SOD, one can suggest the possibility of mandibular involvement in SOD. The presence of a PIK3CA variant may support the hypothesis that these segmental disorders could be part of the PIK3CA-related overgrowth spectrum.
Literature
1.
go back to reference Miles DA, Lovas JL, Cohen MM. Hemimaxillofacial dysplasia: a newly recognized disorder of facial asymmetry, hypertrichosis of the facial skin, unilateral enlargement of the maxilla, and hypoplastic teeth in two patients. Oral Surg Oral Med Oral Pathol. 1987;64:445–8.CrossRef Miles DA, Lovas JL, Cohen MM. Hemimaxillofacial dysplasia: a newly recognized disorder of facial asymmetry, hypertrichosis of the facial skin, unilateral enlargement of the maxilla, and hypoplastic teeth in two patients. Oral Surg Oral Med Oral Pathol. 1987;64:445–8.CrossRef
2.
go back to reference Danforth RA, Melrose RJ, Abrams AM, Handlers JP. Segmental odontomaxillary dysplasia. Report of eight cases and comparison with hemimaxillofacial dysplasia. Oral Surg Oral Med Oral Pathol. 1990;70:81–5.CrossRef Danforth RA, Melrose RJ, Abrams AM, Handlers JP. Segmental odontomaxillary dysplasia. Report of eight cases and comparison with hemimaxillofacial dysplasia. Oral Surg Oral Med Oral Pathol. 1990;70:81–5.CrossRef
3.
go back to reference Smith MH, Cohen DM, Katz J, Bhattacharyya I, Islam NM. Segmental odontomaxillary dysplasia: An underrecognized entity. J Am Dent Assoc. 2018;149:153–62.CrossRef Smith MH, Cohen DM, Katz J, Bhattacharyya I, Islam NM. Segmental odontomaxillary dysplasia: An underrecognized entity. J Am Dent Assoc. 2018;149:153–62.CrossRef
4.
go back to reference Welsch MJ, Stein SL. A syndrome of hemimaxillary enlargement, asymmetry of the face, tooth abnormalities, and skin findings (HATS). Pediatr Dermatol. 2004;21:448–51.CrossRef Welsch MJ, Stein SL. A syndrome of hemimaxillary enlargement, asymmetry of the face, tooth abnormalities, and skin findings (HATS). Pediatr Dermatol. 2004;21:448–51.CrossRef
5.
go back to reference Alshaiji JM, Handler MZ, Huo R, Freedman A, Schachner LA. HATS syndrome: hemimaxillary enlargement, asymmetry of the face, tooth abnormalities, and skin findings. Cutis. 2014;94:E18–21.PubMed Alshaiji JM, Handler MZ, Huo R, Freedman A, Schachner LA. HATS syndrome: hemimaxillary enlargement, asymmetry of the face, tooth abnormalities, and skin findings. Cutis. 2014;94:E18–21.PubMed
6.
go back to reference Prusack N, Pringle G, Scotti V, Chen SY. Segmental odontomaxillary dysplasia: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:483–8.CrossRef Prusack N, Pringle G, Scotti V, Chen SY. Segmental odontomaxillary dysplasia: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:483–8.CrossRef
7.
go back to reference Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998;8:175–85.CrossRef Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998;8:175–85.CrossRef
8.
go back to reference Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998;8:186–94.CrossRef Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998;8:186–94.CrossRef
9.
go back to reference Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606–19.CrossRef Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606–19.CrossRef
10.
go back to reference Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Parker VE, Blumhorst C, Darling T, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A:1713–33.CrossRef Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Parker VE, Blumhorst C, Darling T, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A:1713–33.CrossRef
11.
go back to reference Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA. Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C. 2016;172:402–21.CrossRef Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA. Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C. 2016;172:402–21.CrossRef
12.
go back to reference Madsen RR, Vanhaesebroeck B, Semple RK. Cancer-associated PIK3CA mutations in overgrowth disorders. Trends Mol Med. 2018;24:856–70.CrossRef Madsen RR, Vanhaesebroeck B, Semple RK. Cancer-associated PIK3CA mutations in overgrowth disorders. Trends Mol Med. 2018;24:856–70.CrossRef
13.
go back to reference Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol. 1987;16:899–906.CrossRef Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol. 1987;16:899–906.CrossRef
14.
go back to reference Hare LM, Schwarz Q, Wiszniak S, Gurung R, Montgomery KG, Mitchell CA, et al. Heterozygous expression of the oncogenic Pik3ca(H1047R) mutation during murine development results in fatal embryonic and extraembryonic defects. Dev Biol. 2015;404:14–26.CrossRef Hare LM, Schwarz Q, Wiszniak S, Gurung R, Montgomery KG, Mitchell CA, et al. Heterozygous expression of the oncogenic Pik3ca(H1047R) mutation during murine development results in fatal embryonic and extraembryonic defects. Dev Biol. 2015;404:14–26.CrossRef
15.
go back to reference Mirzaa G, Timms AE, Conti V, et al. PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight. 2016;1(9):e87623.CrossRef Mirzaa G, Timms AE, Conti V, et al. PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight. 2016;1(9):e87623.CrossRef
16.
go back to reference Kuentz P, St-Onge J, Duffourd Y, et al. Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing. Genet Med. 2017;19:989–97.CrossRef Kuentz P, St-Onge J, Duffourd Y, et al. Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing. Genet Med. 2017;19:989–97.CrossRef
18.
go back to reference Chiosea SI, Grandis JR, Lui VW, Diergaarde B, Maxwell JH, Ferris RL, et al. PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma. BMC Cancer. 2013;13:602.CrossRef Chiosea SI, Grandis JR, Lui VW, Diergaarde B, Maxwell JH, Ferris RL, et al. PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma. BMC Cancer. 2013;13:602.CrossRef
19.
go back to reference Munari FF, Cruvinel-Carloni A, Lacerda CF, de Oliveira ATT, Scapulatempo-Neto C, da Silva SRM, et al. PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome. Infect Agent Cancer. 2018;13:43.CrossRef Munari FF, Cruvinel-Carloni A, Lacerda CF, de Oliveira ATT, Scapulatempo-Neto C, da Silva SRM, et al. PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome. Infect Agent Cancer. 2018;13:43.CrossRef
20.
go back to reference Elwy F, Helwa R, El Leithy AA, Shehab El din Z, Assem MM, Hassan NH. PIK3CA mutations in HER2-positive breast cancer patients; frequency and clinicopathological perspective in Egyptian Patients. Asian Pac J Cancer Prev. 2017;18:57–64.PubMedPubMedCentral Elwy F, Helwa R, El Leithy AA, Shehab El din Z, Assem MM, Hassan NH. PIK3CA mutations in HER2-positive breast cancer patients; frequency and clinicopathological perspective in Egyptian Patients. Asian Pac J Cancer Prev. 2017;18:57–64.PubMedPubMedCentral
21.
go back to reference Chen S, Cavazza E, Barlier C, Salleron J, Filhine-Tresarrieu P, Gavoilles C, et al. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets. Oncol Lett. 2016;12:3264–72.CrossRef Chen S, Cavazza E, Barlier C, Salleron J, Filhine-Tresarrieu P, Gavoilles C, et al. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets. Oncol Lett. 2016;12:3264–72.CrossRef
22.
go back to reference Koutlas I, Anbinder A, Alshagroud R. Hemiorofacial asymmetry (hyperplasia/hypoplasia) with associated perineurial hyperplasia and perineuriomatous pseudo-onion bulb proliferations is a segmental orofacial variant of the PIK3CA-related overgrowth spectrum (PROS). Abstract #62; American Academy of Oral and Maxillofacial Pathology Annual Meeting, 2019, Miami FL. Koutlas I, Anbinder A, Alshagroud R. Hemiorofacial asymmetry (hyperplasia/hypoplasia) with associated perineurial hyperplasia and perineuriomatous pseudo-onion bulb proliferations is a segmental orofacial variant of the PIK3CA-related overgrowth spectrum (PROS). Abstract #62; American Academy of Oral and Maxillofacial Pathology Annual Meeting, 2019, Miami FL.
23.
go back to reference Couto JA, Konczyk DJ, Vivero MP, Kozakewich HPW, Upton J, Fu X, et al. Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis. Pediatr Res. 2017;82:850–4.CrossRef Couto JA, Konczyk DJ, Vivero MP, Kozakewich HPW, Upton J, Fu X, et al. Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis. Pediatr Res. 2017;82:850–4.CrossRef
24.
go back to reference McDermott JH, Byers H, Clayton-Smith J. Detection of a mosaic PIK3CA mutation in dental DNA from a child with megalencephaly capillary malformation syndrome. Clin Dysmorphol. 2016;25:16–8.CrossRef McDermott JH, Byers H, Clayton-Smith J. Detection of a mosaic PIK3CA mutation in dental DNA from a child with megalencephaly capillary malformation syndrome. Clin Dysmorphol. 2016;25:16–8.CrossRef
25.
go back to reference Tymen R, Forestier JF, Boutet B. Colomb D [Late Becker's nevus. One hundred cases (author's transl)]. Ann Dermatol Venereol. 1981;108:41–6.PubMed Tymen R, Forestier JF, Boutet B. Colomb D [Late Becker's nevus. One hundred cases (author's transl)]. Ann Dermatol Venereol. 1981;108:41–6.PubMed
26.
go back to reference Danarti R, König A, Salhi A, Bittar M, Happle R. Becker's nevus syndrome revisited. J Am Acad Dermatol. 2004;51:965–9.CrossRef Danarti R, König A, Salhi A, Bittar M, Happle R. Becker's nevus syndrome revisited. J Am Acad Dermatol. 2004;51:965–9.CrossRef
27.
go back to reference Happle R, Koopman RJ. Becker nevus syndrome. Am J Med Genet. 1997;68:357–61.CrossRef Happle R, Koopman RJ. Becker nevus syndrome. Am J Med Genet. 1997;68:357–61.CrossRef
28.
go back to reference Cai ED, Sun BK, Chiang A, Rogers A, Bernet L, Cheng B, et al. Postzygotic mutations in beta-actin are associated with Becker's nevus and Becker's nevus syndrome. J Invest Dermatol. 2017;137:1795–8.CrossRef Cai ED, Sun BK, Chiang A, Rogers A, Bernet L, Cheng B, et al. Postzygotic mutations in beta-actin are associated with Becker's nevus and Becker's nevus syndrome. J Invest Dermatol. 2017;137:1795–8.CrossRef
29.
go back to reference Kim HJ, Kim KD, Lee MH. Becker's melanosis associated with fibrous dysplasia. Int J Dermatol. 2002;41:384–6.CrossRef Kim HJ, Kim KD, Lee MH. Becker's melanosis associated with fibrous dysplasia. Int J Dermatol. 2002;41:384–6.CrossRef
Metadata
Title
Segmental Ipsilateral Odontognathic Dysplasia (Mandibular Involvement in Segmental Odontomaxillary Dysplasia?) and Identification of PIK3CA Somatic Variant in Lesional Mandibular Gingival Tissue
Authors
Tanya M. Gibson
Keith Rafferty
Elyse Ryan
Arupa Ganguly
Ioannis G. Koutlas
Publication date
01-03-2021
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2021
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-020-01185-5

Other articles of this Issue 1/2021

Head and Neck Pathology 1/2021 Go to the issue